Ignite Creation Date:
2025-12-25 @ 2:49 AM
Ignite Modification Date:
2026-03-03 @ 12:03 AM
Study NCT ID:
NCT01373333
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2016-07-20
First Post:
2011-06-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome
Sponsor:
The Cleveland Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1997-09
Start Date Type:
None
Primary Completion Date:
2012-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2011-06-13
First Submit QC Date:
None
Study First Post Date:
2011-06-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-07-18
Last Update Post Date:
2016-07-20
Last Update Post Date Type:
ESTIMATED